Laser vitreolysis of floating opacities in the vitreous body
https://doi.org/10.37895/2071-8004-2018-22-4-23-27
Abstract
Objective: To evaluate the effectiveness of YAG-laser vitreolysis using the quantitative assessment of floating opacities in the vitreous body. Material and methods. In September 1, 2016 – March 26, 2018, YAG-laser vitreolysis was performed in 191 patients (228 eyes). The indication for the operation was floating opacities of the ring Weiss type and absence of retina pathologies. Patients’ age – 36–86, average age – 63.2 ± 9.9. Men – 35, women – 156. Before and after the surgery there were performed traditional and additional examinations: ultrasonography, optical coherence tomography (OCT) with angiography function, scanning laser ophthalmoscopy. Results. Findings of OCT-angiography examination of 228 eyes in the postoperative period showed residual opacities in the form of artifact shadow on the retina surface at the following periods: one day – in 52 eyes, 1 week – in 12 eyes, 1 month – in 5 eyes, 3 months – in 1 eye. All patients had an additional session of laser vitreolysis. Next examination in 6 and 12 months did not reveal any opacities. According to the survey, total patients’ satisfaction was 89.5%. Conclusion. The quantitative assessment of floating vitreous opacities, determined by the area of the artifact shadow on the retinal surface with OCT-angiography, is an objective method for optimizing indications for laser vitreolysis and evaluating the effectiveness of treatment in the postoperative period.
About the Authors
V. A. Shaimova
Multiprofle Center of Laser Medicine;
Vision center, Ltd.
Russian Federation
Chelyabinsk
Russian Federation
Chelyabinsk
T. B. Shaimov
Vision center, Ltd.
Russian Federation
Chelyabinsk
Russian Federation
Chelyabinsk
A. Yu. Galin
Vision center, Ltd.
Russian Federation
Chelyabinsk
Russian Federation
Chelyabinsk
R. B. Shaimov
Vision center, Ltd.
Russian Federation
Chelyabinsk
Russian Federation
Chelyabinsk
A. I. Kozel
Multiprofle Center of Laser Medicine
Russian Federation
Chelyabinsk
Russian Federation
Chelyabinsk
R. U. Giniatullin
Multiprofle Center of Laser Medicine
Russian Federation
Chelyabinsk
Russian Federation
Chelyabinsk
Zh. A. Goloshchapova
Multiprofle Center of Laser Medicine
Russian Federation
Chelyabinsk
Russian Federation
Chelyabinsk
T. G. Kravchenko
Multiprofle Center of Laser Medicine
Russian Federation
Chelyabinsk
Russian Federation
Chelyabinsk
A. K. Goloshchapova
Vision center, Ltd.
Russian Federation
Chelyabinsk
Russian Federation
Chelyabinsk
References
1. Fedorov S.N. Laser treatments of eye disease. M.: Medicine, 1990: 115.
2. Shaimova V.A., Shaimov R.B., Shaimov T.B. et al. An objective method for quantifying floating opacities in the vitreous body by the area of the artifact shadow in the retina layers for evaluating the effectiveness of YAG laser vitreolysis. Vestnik oftalmologii. 2018; 134 (1): 56–62.
3. Laser surgery of vascular pathologies of the ocular fundus / edited by A. Schuko. – M.: Ophthalmology publishing house, 2014: 256.
4. Adhi M., Duker J.S. Optical coherence tomography – current and future applications. Curr Opin Ophthalmol. 2013; 24 (3): 213–221.
5. Delaney Y.M., Oyinloye A., Benjamin L. Nd: YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters. Eye. 2002; 16: 21–26.
6. Huang L.C., Yee K., Wa C.A. et al. Vitreous floater s and vision – current concept sand management paradigms. In: Sebag J., ed. Vitreous – in health and disease. New York: Springer, 2014: 771–788.
7. Ivanova T., Jalil A., Antoniou Y. et al. Vitrectomy for primary symptomatic vitreous opacities: an evidence – based review. Eye (Lond). 2016; 30 (5): 645–655.
8. Karickhoff J.R. Laser treatment of eye floaters, Washington Medical Publishing, LLC. Falls Church, VA, 2005.
9. Kennelly K.P., Morgan J.P., Keegan D.J., Connell P.P. Objective assessment of symptomatic vitreous floaters using optical coherence tomography: a case report. BMC Ophthalmol. 2015; 15: 22. doi:10.1186/s12886-015-0003-5.
10. Mamou J., Wa C.A., Yee K.M. et al. Ultrasound-based quantifcation of vitreous floaters correlates with contrast sensitivity and quality of life. Invest Ophthalmol Vis Sci. 2015; 56 (3): 1611–1617.
11. Milston R., Madigan M.C., Sebag J. Vitreous floaters: etiology, diagnostics, and management. Surv. Ophthalmol. 2016; 61: 211–227.
12. Shah C.P., Heier J.S. YAG Laser vitreolysis vs sham yag vitreolysis for symptomatic vitreous floaters: a randomized clinical trial. JAMA Ophthalmol. 2017; 135 (9): 918–923.
13. Schwartz S.G., Flynn H.W., Fisher Y.L. «Floater scotoma» demonstrated on spectral domain optical coherence tomography and caused by vitreous opacifcati on. Ophthalmic Surg Lasers Imaging Retina. 2013; 44 (4): 415–418.
14. Shaimova V., Shaimov T., Shaimov R. Peripheral retinal degenerations: optical coherence tomography and retinal laser coagulation. Cham: Springer International Publishing, 2017.
15. Vandorselaer T., Van De Velde F., Tassignon M.J. Eligibility criteria for Nd –YAG laser treatment of highly symptomatic vitreous floaters. Bull Soc Belge Ophtalmol. 2001; 280: 15–19.
16. Wagle A.M., Lim W.Y., Yap T.P., Neelam K., Au Eong K.G. Utility values associated with vitreous floaters. Am. J. Ophthalmol. 2011; 152: 60–65.
17. Webb B.F. Prevalence of vitreous floaters in a community sample of smartphone users. Int. J. Ophthalmol. 2013; 6 (3): 402–405.
Review
For citations:
Shaimova V.A., Shaimov T.B., Galin A.Yu., Shaimov R.B., Kozel A.I., Giniatullin R.U., Goloshchapova Zh.A., Kravchenko T.G., Goloshchapova A.K. Laser vitreolysis of floating opacities in the vitreous body. Laser Medicine. 2018;22(4):23-27. (In Russ.) https://doi.org/10.37895/2071-8004-2018-22-4-23-27
Views:
542
Email this article 